Abstract:Efforts to develop new drug-based therapeutic approaches against Intestinal Bowel Disease (IBD) must overcome several challenges, including issues of delivery, potential off-target effects, safety, toxicity, large-scale production costs and tissue specificity. We and other groups have recently demonstrated that artificially synthesized nanoparticles may be used to specifically deliver low doses of drugs (e.g., siRNAs, proteins and peptides) to certain cell types or tissues. However, the synthetic nanoparticles have, to date, 2 major limitations: (1) the potential toxicity of each of their constituent that has to be tested prior to clinical application; and (2) their limited production scale. The use, for IBD treatment, of nanoparticles derived from natural sources may overcome these limitations. Ginger, which contains many anti-inflammatory compounds, has been used as traditional medicine for centuries. Here, we isolated natural nanoparticles from ginger, tested their efficacy for targeting the colon and assessed their intrinsic anti-inflammatory potential using the well-established model of Dextran Sulfate Sodium (DSS) induced-colitis. The size distribution of ginger derived nanoparticles (GDNPs) was determined using multiple approaches: photon correlation spectroscopy (PCS), Atomic Force Microscopy (AFM) and scattering electron microscopy (EM). The average size of GDNPs was ∼220 nm. Interestingly, we demonstrated that the retention of orally administered GDNPs in the colon was higher in non-starved mice than in starved mice, suggesting a natural and efficient way of administering GDNPs. We observed that DSS-induced acute inflammation was attenuated by a specific population (GDNPs 2) as reflected by a reduced spleen weight, an increased colon length, a reduced MPO level and histological examination. We also showed that GDNPs 2 reduced the expression of pro-inflammatory cytokines, such as TNF-α, IL6 and IL-1β, and increased the expression of anti-inflammatory cytokines, including IL-10 and IL-22, demonstrating that GDNPs 2 blocked some factors that damage the intestines (TNF-α, IL-6 and IL-1β) while promoting factors that heal the intestines (IL-10 and IL-22). We anticipate that this study will represent a proof of principle for a novel natural, nontoxic delivery system that targets the inflamed intestinal mucosa, blocks damaging factors while promoting healing factors and may easily be developed for large-scale production aimed at the treatment of IBD.

Dual Functional Eudragit® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis

Crgd Peptide Incorporated with Patchouli Alcohol Loaded Silk Fibroin Nanoparticles for Enhanced Targeting of Inflammatory Sites in Colitis.

Dual-Sensitive Carbohydrate-Based Nanosystem for Targeted Drug Delivery to Potentiate the Therapeutic Efficacy of Ulcerative Colitis

Colon-targeted Oral Nanoparticles Based on ROS-scavenging Hydroxyethyl Starch-Curcumin Conjugates for Efficient Inflammatory Bowel Disease Therapy.

Colon-Targeting Angelica sinensis Polysaccharide Nanoparticles with Dual Responsiveness for Alleviation of Ulcerative Colitis

P084 ORAL DELIVERY OF NANOPARTICLES LOADED WITH GINGER ACTIVE COMPOUND, 6-SHOGAOL, ATTENUATES ULCERATIVE COLITIS AND PROMOTES WOUND HEALING IN A MURINE MODEL OF ULCERATIVE COLITIS

Dual‐Targeted Nanoparticle‐In‐Microparticle System for Ulcerative Colitis Therapy

Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis

Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis

Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice

Colon-targeted piperine-glycyrrhizic acid nanocrystals for ulcerative colitis synergetic therapy via macrophage polarization

Colon-targeted piperine-glycyrrhizic acid nanocrystals for ulcerative colitis synergetic therapy <i>via</i> macrophage polarization

Multi-targeting Inulin-Based Nanoparticles with Cannabidiol for Effective Prevention of Ulcerative Colitis

Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh2 for effective treatment of ulcerative colitis

P-139 YI Ginger Derived Nanoparticles

Co-delivery of Resveratrol and Curcumin Based on Mesona Chinensis Polysaccharides/zein Nanoparticle for Targeted Alleviation of Ulcerative Colitis

Oral colon-targeted pH-responsive polymeric nanoparticles loading naringin for enhanced ulcerative colitis therapy

Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment

Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome

Protective Effect of Iridoid Glycosides of the Leaves of Syringa oblata Lindl. on Dextran Sulfate Sodium-Induced Ulcerative Colitis by Inhibition of the TLR2/4/MyD88/NF-κB Signaling Pathway

Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model